AU Patent

AU2015228541B2 — Nasal drug products and methods of their use

Assigned to Opiant Pharmaceuticals Inc · Expires 2020-09-03 · 6y expired

What this patent protects

Drug products adapted for nasal delivery, comprising a pre-primed device filled with a pharmaceutical composition comprising an opioid receptor antagonist, are provided. Methods of treating opioid overdose or its symptoms with the inventive drug products are also provided.

USPTO Abstract

Drug products adapted for nasal delivery, comprising a pre-primed device filled with a pharmaceutical composition comprising an opioid receptor antagonist, are provided. Methods of treating opioid overdose or its symptoms with the inventive drug products are also provided.

Drugs covered by this patent

Patent Metadata

Patent number
AU2015228541B2
Jurisdiction
AU
Classification
—
Expires
2020-09-03
Drug substance claim
No
Drug product claim
No
Assignee
Opiant Pharmaceuticals Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.